Rhumbline Advisers Grows Position in AnaptysBio, Inc. (NASDAQ:ANAB)
Rhumbline Advisers increased its position in shares of AnaptysBio, Inc. (NASDAQ:ANAB – Free Report) by 2.7% during the first quarter, HoldingsChannel reports. The institutional investor owned 30,903 shares of the biotechnology company’s stock after buying an additional 826 shares during the quarter. Rhumbline Advisers’ holdings in AnaptysBio were worth $574,000 as of its most recent […]
Rhumbline Advisers increased its position in shares of AnaptysBio, Inc. (NASDAQ:ANAB – Free Report) by 2.7% during the first quarter, HoldingsChannel reports. The institutional investor owned 30,903 shares of the biotechnology company’s stock after buying an additional 826 shares during the quarter. Rhumbline Advisers’ holdings in AnaptysBio were worth $574,000 as of its most recent […]
